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Interdomain movementPhospholipase Cβ2 (PLCβ2) is a large, multidomain enzyme that catalyzes the hydrolysis of the signaling lipid
phosphoinositol 4,5 bisphosphate (PIP2) to promotemitogenic and proliferative changes in the cell. PLCβ2 is ac-
tivated by Gα and Gβγ subunits of heterotrimeric G proteins, as well as small G proteins and speciﬁc peptides.
Activation depends on the nature of the membrane surface. Recent crystal structures suggest one model of acti-
vation involving themovement of a small autoinhibitory loop uponmembrane binding of the enzyme. Addition-
ally, solution studies indicate multiple levels of activation that involve changes in the membrane orientation as
well as interdomainmovement. Here,we review thewealth of biochemical studies of PLCβ2-Gprotein activation
and propose a comprehensive model that accounts for both the crystallographic and solution results.+1 631 444 3432.
arlata).
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Mammalian phospholipase C-β2 (PLCβ2) can be thought of as a pro-
totype signaling enzyme. This multidomain enzyme is themain effector
of signals emanating from activation of the Gαq family of heterotri-
meric G proteins and has several established activators [1,2]. However,
only its basic catalytic core can be found in single cell organisms, leading
to the conclusion that as the enzyme evolved in higher organisms, reg-
ulatory domainswere attached to the catalytic domain to control the in-
teraction with other macromolecules, cellular localization and catalytic
regulation. As the number of domains increased, so too did the number
of activators of this enzyme. Here we focus on the implications of this
increase in the number of activation mechanisms due to the increased
number of activators. Structural studies have suggested a single univer-
sal activation mechanism as discussed below, whereas solution studies
suggest multiple activation pathways. In this review, we highlight the
role of regulatory domains in enzyme activity and the attendant activa-
tion mechanisms. After a brief overview of the domain organization of
the enzyme, we describe the catalytic mechanism and show how regu-
latory domains may produce different modes of enzyme activation.2. PLCβ2 is composed of conserved structural domains
The regulatory domains of PLCβ2 are involved in protein–protein,
protein–lipid and protein–substrate interactions including those that
control activation and cellular localization (for review see [1–3]). The
organization of these domains is shown in Fig. 1 in comparison to the
cognate mammalian PLC, PLCδ. The catalytic domain is close to the cen-
ter of the enzyme sequence. The core of this domain consists of two
halves, referred to as X and Y and composed of alternating α helices
and β strands that form an α/β barrel with the catalytic end on one
side of the barrel [4–6]. Between the two halves of that core is an inter-
vening sequence that is not integral to the core's structure. The nature of
this insertion loop varies for different mammalian PLCs. In PLCβ2, this
region contains a long, almost consecutive stretch of ~18 D/E residues
(Fig. 1C). In the crystal structure of the homologous enzyme PLCδ1 [7]
and of Rac1-PLCβ2 [4], this region is disordered, but in the crystal struc-
ture of isolated PLCβ2 [5], the loop occludes the active site. This posi-
tioning of the linker led to the suggestion that activation involves
detachment of the loop, presumably due to charge repulsion from the
membrane surface [5]. Interestingly, in PLCγ the insertion region con-
tains a split PH domain, two SH2 domains and an SH3 domain, which
are integral to enzyme activation [8]. Comparison of the catalytic resi-
dues of the bacterial PLC to those of mammalian PLCδ1 and PLCβ2
shows a very similar placement of active site amino acids; the active
site utilizes a Ser/His triad with water as an active participant in the re-
action [9–11]. Calcium functions as a chelator in the reaction and is
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Fig. 1. A. Comparison of the domain organization of PLCβ and PLCδ enzymes; B. Top and side views of the domain structure of PLCβ2 from Ref. [5] where the PH domain is in purple,
the EF hands are in green, the catalytic domain is in medium (X) and dark (Y) brown and the C2 domain is in blue. Active site residues are depicted in ball and stick, and the two
residues attached to the insertion region are in CPK; C. Sequence comparison of the X/Y linker insertion regions of PLCδ1 and PLCβ2.
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concentrations whereas PLCδ is active only at elevated Ca2+ generated
by the activity of other PLCs.
The PLCβ enzymes contain a pleckstrin homology (PH) domain in
their N-terminal region. PH domains are highly conserved motifs of
~120 amino acids that, in general, confer speciﬁcity for different lipids
or proteins [12]. These domains, whichwere discovered almost two de-
cades ago, are among the most commonmotifs in mammalian proteins
(Fig. 2). It was previously shown that the PH domain of PLCδ1 targeted
the enzyme to membranes containing its substrate, PIP2 [13] through a
series of speciﬁc hydrogen bonds and ionic interactions [14]. These in-
teractions ensure that the enzyme remains membrane-bound and
close to its substrate until PIP2 is depleted. In contrast, the PIP2-binding
residues are absent in the PH domain of PLCβ2 enzymes (Fig. 2) but the
protein binds strongly to membranes with little speciﬁcity [15], as dis-
cussed further below. In addition to membrane binding, the PH domain
of PLCβ2 mediates association to monomeric G proteins and to Gβγ
subunits [16–19].
Following the PH domain are two EF hands (Fig. 1A). The role of
these domains in the regulation of PLCβ2 is unclear; while little work
has been done to elucidate their function, we note that deletion of this
region of PLCδ1 inactivates the enzyme [20]. Additionally, the EF
hands of PLCδ1 do not appear to bind Ca2+ (see discussion in [1]) but
could interact with lipids [21]. There is no evidence that this region of
PLCβ2 binds Ca2+ as none is observed in the crystal structures [4–6].
A recent structure of a Gαq construct in complex with truncated
PLCβ2 shows several contact sites between the EF hands and Gαq sug-
gesting that this region may play a role in Gαq binding [6].
Downstream of the catalytic domain is a C2 domain (Fig. 1A). Al-
though C2 domains are usually associated with Ca2+-dependent mem-
brane targeting, this is not the case for PLCβ2 since the C2 domains
lack the appropriate residues to chelate Ca2+ (see Ref. [22]). Althoughthe C2 domains do not bind strongly to membranes in isolation, they
bind strongly and speciﬁcally to activated Gαq subunits, as discussed
below [22].
PLCβ enzymes have a unique 400 residue extension at their C-terminal
end. This region is necessary for activation by Gαq subunits [23–25]. Inter-
estingly, this region contains an RGS domain that promotes the deactiva-
tion of Gαq subunits [26], and the kinetic aspects of the activation of
these G proteins have been reviewed recently [27]. The C-terminal region
also contains other segments that regulate the cellular activity of PLCβ, in-
cluding two phosphorylation sites and a nuclear localization signal [1].
While the structure of the isolated C-terminal region has been solved
[28], this region was absent in the crystal structures of the PLCβ enzymes
solved so far. The C-terminal region crystallizes as an intertwineddimer al-
though the puriﬁed formof PLCβ appearsmonomeric up to 200 nMas de-
termined using Förster resonance energy transfer methods (Scarlata,
unpublished). Computational studies and mutagenesis of the C-terminal
domain correlate with Gαq activation of the dimeric form [29]. This region
is not required for enzymeactivationbyGβγ subunits [30] andmonomeric
G proteins [4].
3. PLCβ catalyzes the hydrolysis of PIP2 in a two step reaction
pathway
While PLCβ2 can catalyze the hydrolysis PI and PIP, PIP2 is the pre-
ferred substrate. Catalysis has been shown to occur via a two step path-
way [11] as shown in Fig. 3. Theﬁrst step yields a cyclic phosphoinositide
and this is the terminal product of bacterial enzymes under most condi-
tions. Inmammalian PLCs, this cyclic intermediate is held in the catalytic
site long enough to be attacked by water to yield a mixture of linear and
cyclic products [31–33]. PLCβ, unlike PLCδ and PLCγ enzymes, only pro-
duces linear product suggesting stronger binding of cyclic IP in the cata-
lytic site [34]. It has been shown that the presence of Gβγ increases the
Fig. 2. Comparison of the structures (TOP) of PH-PLCβ2 with residues 71–88 rendered in stick format, and PH-PLCδ1 complexed with Ins(1,3,5)trisphosphate (in stick format);
(BOTTOM) sequences of the PH domains of PLCβ2 and PLCδ1 where the residues of PHδ1 important for IP3 binding are in red and underlined, and the residues in the insertion
unique to PHβ2 are in underlined italics.
Adapted from Ref. [9].
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not clear whether cells utilize the cyclic and linear IP3 differently, and
so the ability of PLCβ2 to produce linear IP3 has as yet unknown
signiﬁcance.
4. Enhancement of PLCβ activity can occur through several steps
in the reaction pathway
Since PLCβ2 is a soluble enzyme that hydrolyzes a lipid substrate,
there are many potential steps in the catalytic mechanism that can be
inﬂuenced by activators. One or all of these steps may involve confor-
mational changes in the enzyme. Importantly, PLCβ2 must bind to the
membrane surface to access its substrate, and this access might involve
penetration of the enzyme into the lipid surface. Catalytic steps that in-
volve substrate access are expected to depend on the physical proper-
ties of the lipid aggregate, and in particular the lipid head groups. The
potential role of these steps in the activation process is discussed below.Fig. 3. Reaction scheme of PIP2 hydroPLCβ1-3 enzymes have been shown to bind strongly and non-
speciﬁcally to membranes with varying composition [15]. Unlike PLCδ,
which only binds strongly to membranes containing PIP2, PLCβ1-3 en-
zymes bind with similar afﬁnity to bilayers with electrically neutral
and negatively charged head groups, although PIP2-speciﬁc binding
has been noted in some reports [36]. It is notable that binding is slightly
stronger to membranes containing lipids with phosphoethanolamine
(PE) head groups which, depending on the mixture composition and
temperature, have been observed to form hexagonal phases to various
extents [37].
Several regions of PLCβ2 may contribute to membrane binding.
The C-terminal region of PLCβ2 has some contribution to binding af-
ﬁnity but its impact does not appear to be substantial [15]. The iso-
lated catalytic domain of the highly homologous PLCδ1 does not
interact with membranes and its intrinsic afﬁnity to PIP2 is very
low [38]. As mentioned above, PH-PLCβ2 has been shown to play a
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Fig. 4. A. (Left) Snapshot from the coarse-grained simulation of PH-PLCβ2 (residues 1–144) interacting with a membrane model. The beads representing the lipid chains are shown
in light gray, the choline group bead is shown in orange and the phosphate group bead is in blue. The larger colored beads are the ﬁrst 10N-terminal residues as they insert in the
membrane. (Left) In the top left structure the beads of the N-terminal Met are in yellow and the beads of the four leucines oriented into the membrane are rendered in pink. The rest
of the protein is shown as a cartoon, colored according to secondary structure. (Right) The same structure rotated 180°. The open space in the center of the structure corresponds
roughly to the PIP2 binding site of PLC-delta1 if it were superimposed onto this structure. B. Binding curve to POPC membranes for PHβ2 and Δ10-PHβ2. Binding was measured as a
function of concentration using ﬂuorescence methods (adapted from Ref. [65]). C. Activation of the PHβ2-PLCδ1 chimera by Gβ86-105 (see Section 5) measured in membranes of
different composition (adapted from Ref. [41]).
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the manner in which PLCβ2 binds to membranes is unclear. Theoret-
ical studies of membrane binding of the PH-PLCβ2 domain suggest
that the binding involves penetration of the ﬁrst 10 residues of the
domain into the lipid matrix (Fig. 4A) [41]. This prediction was sub-
stantiated by experimental studies showing that removal of the ﬁrst
10 residues results in a signiﬁcant loss in binding afﬁnity (Fig. 4B and
[65]). These residues were absent in the PLCβ constructs that were
crystallized.
In searching for regions of PH-PLCβ2 thatmight confer activation by
Gβγ subunits, an insertion (71–88) was identiﬁed that is absent in PH-
PLCδ (see alignment in Fig. 2). A peptide generated from this sequence
(underlined and italicized in Fig. 2) bound strongly to lipid membranes
containing PE lipids [41]. Surprisingly, when added to PLCβ2, this seg-
ment (PH71–88) is able to activate the enzyme to the same level as
Gβγ subunits.
Because PLCβ2 is soluble and G proteins reside on membrane sur-
faces, activation of PLCβ2 by G proteins was thought to occur through
the recruitment of the enzyme to the membrane by activated G pro-
teins. We had explicitly tested this idea using model systems where
the concentrations of proteins and lipids can be carefully controlled
[42,43], and found that, under excess lipid conditions, association be-
tween G protein subunits and PLCβ2 occurs between the membrane-
bound proteins on the surfaces of membranes. Similar ﬁndings have
been reported from other studies [36]. Association between the pre-
bound proteins is promoted by the effective reduction of dimensional-
ity and a more limited number of available protein association sites
[43]. Notably, this mode of interaction between membrane-bound
proteins differs from an alternative mechanism, of simultaneous
membrane recruitment of PLCβ2 by G protein binding (see discussion
in Ref. [43]).5. G protein activators bind at different regions of the enzyme
In the early 1990s it was established that Gαq and Gβγ interact with
different regions of PLCβ2 to promote activation ([25] and see Refs.
[44,45]). Speciﬁcally, it was shown that deletion of the C-terminal region
ablates activation by Gαq subunits even though the truncated enzyme
will still bind Gαq with a reduced afﬁnity [22]. It was further shown
that the C2 domain located next to the C-terminal region was responsi-
ble for speciﬁc binding to activated Gαq [22]. The structure of a complex
between an activated Gαq construct and the C-terminal truncated
PLCβ3 has recently been solved and shows interaction between the C2
domain and Gαq, although activation of the enzyme by Gαq was not
demonstrated [6]. More recent studies suggest that Gαq activation oc-
curs when the G protein displaces an inhibitory interaction between
the C-terminal extension and the catalytic domain [46].
Many studies have addressed the interaction between PLCβ2 and
Gβγ. Contact sites have been mapped to residues in the catalytic do-
main, and in the PH domain [47–52]. Additionally, the PH domain has
been shown to bind to Gβγ subunits with an afﬁnity only 5 fold
weaker than the full length enzyme [16]. Swapping this domain into
PLCδ1, which is not activated by Gβγ, results in an enzyme that is
fully activated by Gβγ subunits [53]. As mentioned, PLCδ1 speciﬁcally
binds to PIP2 through residues in its PH domain, and binding to PIP2-
results in enzyme activation [54]. Interestingly, swapping the PH do-
main of PLCδ1 into PLCβ2 results in an enzyme that speciﬁcally
targets PIP2-containing membranes and allows for PIP2-mediated
activation [52].
Some additional activators of PLCβ2 have been identiﬁed, includ-
ing Rac1 from the Rac family. These small G proteins are thought to
activate the enzyme by promoting membrane binding, which is
most likely the reason this activation difﬁcult to assess in vitro (see
2944 H. Weinstein, S. Scarlata / Biochimica et Biophysica Acta 1808 (2011) 2940–2947[55,56], and for review [57]). A recent crystal structure of the Rac1-
PLCβ2 complex shows that association between the proteins is medi-
ated entirely by the PH-PLCβ2 domain, with no additional contacts
in other regions of the enzyme [4]. Since Rac1 does not contact the
catalytic residues and does not appear to induce conformational
changes, it is unclear how it activates the enzyme aside from driving
membrane binding. It has been postulated that in vitro activation by
Rac1 is only seen under very limited experimental conditions, and
that the Rac1-PLCβ2 complex can be activated further by G protein
subunits (e.g. [4]).
PLCβ2 can also be activated by several types of peptides. Peptides
with sequences corresponding to regions in the catalytic domain
have been shown to increase catalytic activity by some unknownmech-
anism [58,59]. A dodecapeptide with a sequence corresponding to a
blade of the Gβγ propeller, Gβ86-105, not only activates the enzyme
but will also increase level of activation of the Gβγ-PLCβ2 complex, im-
plying that multiple levels of activation exist [60]. Peptide studies have
identiﬁed other Gβ regions that are involved in PLCβ2 binding [61].
Probably one of the most interesting activators is the peptide derived
from the 71–88 segment of PH-PLCβ2 [41], as mentioned above. The
region corresponding to this peptide is thought to induce activation
by favorably positioning the enzyme on the membrane surface (see
below) although it is possible that this region forms an amphipathic,
mostly cationic helix that might compete with the anionic linker for
activation.
6. Both the activity, and G protein activation, of PLCβ2 strongly de-
pend on the properties of the membrane surface
The activity of PLCβ2 is almost always measured using a radiomet-
ric assay that monitors the release of soluble 3H-IP3 from 3H-PIP2 hy-
drolysis. PIP2 is usually dispersed in either mixed micelles or lipid
bilayers. Little change in PLCβ2 activity is observed as a function of
the charge of the membrane surface. Although PE lipids support
slightly higher levels of activity (see Ref. [41]), this increase is thought
to be due to a reduction of membrane surface tension caused by PE
(since activity towards substrate immersed in micelles is lower than
in bilayers).
The dependence of Gαq activation on membrane composition has
not been thoroughly investigated, and activation by monomeric G pro-
teins can be seen only under very limited experimental conditions, but
Gβγ activation has been shown to have a signiﬁcant dependence on
membrane composition. Activation of PLCβ2 or the PHβ2-PLCδ1 chimera
does not occur when PIP2 is embedded in PC bilayers, and activation is
very low in negatively charged PC:PS membranes. However, incorpora-
tion of PE lipids allows for enzyme activation [41] and Fig. 4C. Similarly,
activation by Gβ86-105, which does not bind membranes, does not
occur on PC membranes [41] showing that the inability of Gβγ to active
the enzyme on PC membranes (compared to PE-containing surfaces) is
not due to differences in the orientation relative to the membrane, or
to binding of the G protein subunit.
Even though negatively charged lipids do not affect Gβγ activa-
tion, it has been found that large quantities of anionic PA lipids, but
not anionic PG lipids can activate PLCβ1 [62]. This apparent electro-
static mode of activation has been thought to be mediated through
a region located in the C-terminal region of PLCβ1 that targets PA
lipids.
7. Detachment of the insertion loop as a model for activation
For almost two decades biochemical studies have sought to under-
stand the pathway through which G protein subunits activate PLCβ en-
zymes, sustained by the expectation that structural studies would
ultimately reveal the various conformational changes that seemed to
be associated with activation. However, crystal structures of PLCβ en-
zymes alone [5], complexed with Rac1 [4] or with a Gαq construct [6],showed little differences in backbone conformations. As mentioned,
the only signiﬁcant difference in these structures was the position of
an anionic linker loop between the two major folds of the catalytic do-
main (Fig. 1), which contacts the catalytic domain in the absence of G
proteins and is unresolved in thepresenceof activator.Whilemovement
of this linker will certainly allow for increased activity [39], it is not clear
how G proteins would promote this movement since it appears that
they do not directly contact this region of the catalytic domain, and
since no othermovement is observed to occur in the backbone residues.
Because the linker contains so many negatively charged residues
(Fig. 1C), the detachment of this anionic loop from the active site was
proposed to occur when the enzyme binds to membrane surfaces and
to be due to charge repulsion from the phosphates of the lipid head
groups [5]. Thus, activation by G proteins could occur if the G proteins
recruited the enzyme to the membrane surface. However, with this ex-
planation it remains unclear how the detachment of the loop observed
in the crystals of the complex would occur in the absence of the nega-
tively charged membrane headgroups, and leaves open the questions
of how G proteins alone can affect the interaction between the loop
and the catalytic site, or how Gβγ activation occurs in the PHβ2-PLCδ1
chimera which has a very different insertion sequence (Fig. 1C). Activa-
tion through changes in the insertion region has been proposed for PLCγ
which has a much larger and more complex insertion [8].
While the anionic insertion is autoinhibitory and its removal plays a
role in the activation of PLCβ2 and other PLC families [5], it is clearly not
the only pathway of PLCβ2 activation and there are several reasons to
suggest that activation is more complex. First, although deletion of
this anionic linker in PLCβ2 results in a more active enzyme, it does
not affect the enzyme's ability to be activated by G protein subunits
[5,39]. Second, the observation that Gβγ can further activate Rac1-
PLCβ2, whose crystal structure is thought to correspond to this inser-
tion-activated form, does not ﬁt with this model as the sole activation
mode [4]. Third, the linker-based activationmodel predicts that the cat-
alytic domain, but not the PHdomain, interactswith themembrane sur-
face and this contradicts studies showing that the PH domain is
required for membrane binding of the host enzyme [38,39]. Fourth,
the simple structure-basedmodel cannot account for themany solution
studies of PLCβ2 activation by Gβγ subunits, and the analogous activa-
tion of PLCδ1 by PIP2, that show that Gβγ activation occurs through PH
domain membrane binding and changes in membrane and domain ori-
entation (e.g. [41,54]); nor can this model account for activation by the
Gβ86-105. Fifth, this model cannot account for the observation that
Gβγ activates PLCβ2 catalysis of soluble cIPs as well as membrane-
bound PIP2 [35]. Finally, there appear to be multiple levels of PLCβ2 ac-
tivation, which is inconsistent with a simple model based on the loop
detachment [60].
8. Comprehensive model of PLCβ activation states
In searching for a more comprehensive understanding of the multi-
ple potential levels of PLCβ2 activation, we reasoned that a model that
would agree with both solution and crystallographic data would have
both the isolated PLCβ2 structure, and the bound G protein, correspond
to an activated form of the enzyme. One of the inactive forms would
maintain the contacts between the loop region and the catalytic site,
and the other would not. This idea is consonant with the observedmul-
tiple levels of PLCβ2 activation and implies that other deactivated forms
of the enzyme exist. Others have also made this suggestion [27].
In searching for deactivated structureswe began by considering pre-
vious and ongoing work showing that the PH domain targets the en-
zyme to membrane surfaces through penetration of the ﬁrst 10 amino
acids ([41] and [65]). However, it became clear from the structural con-
straints that directing the enzyme to themembrane by interactionwith
the PH domain anchored through its N-terminal region positions the
catalytic domain too far from themembrane surface to enable substrate
access (Fig. 5a).
ab
Fig. 5. Computational model of the docking of the PH and catalytic domains of PLCβ2 to
a lipid membrane. a. Result of computational docking with the ﬁrst 10 residues of the
PH domain penetrating into the lipid bilayer. b. Model of the pre-active form of
PLCβ2 in which the PH domain has reoriented to allow for active site contact with
the membrane surface.
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form of the enzyme, it does not make it immediately clear how the en-
zyme would be activated. We approached a solution to this problem by
keeping in mind two key experimental ﬁndings that Gβγ activation is
greatly promoted by PE-containing membrane surfaces, but not by PC
surfaces, and that the orientation of the PH domain relative to the cata-
lytic domain changes upon binding to PE surfaces and upon Gβγ binding
([41] and [65]). Insight into the molecular details that would support an
activationmodel that agrees with these key experimental ﬁndings came
from comparative coarse-grainedmolecular dynamics simulations of the
interaction of the isolated PH-PLCβ2 with PC membranes containing in-
creasing amounts of PE lipids ([65]). Binding to pure PC membranes
occurredwith the predicted penetration of the N-terminus of the PH do-
main leading to a stablemembrane-bound structure. However, the pres-
ence of PE membranes was shown to change the mode of interaction,
leading to the appearance of a second orientation of the PH domain rel-
ative to themembrane surface (Fig. 5b). In this orientation, PH71–88, the
region of the PH domain that is found in PLCβ2, but not PLCδ [41], could
interact with the catalytic domain. Direct interaction of PH71–88 with
the catalytic domain is consistentwith the ability of this peptide to inter-
fere with membrane interactions of the catalytic domain but not the PH
domain [41]. Complementing the complex by attaching the catalytic do-
main to such a “pre-active state” orientation of the PH domain, and com-
putationally optimizing the domain contacts, results in the conﬁguration
presented in Fig. 5b. This orientation of the PLCβ2 domains places the
catalytic domain close to the membrane surface and allows the enzyme
to access substrate.Bringing together the results of the computational modeling and ex-
perimental studies,wepropose the followingmodel of activation. The ini-
tial interaction of the enzyme to the membrane surface is through the N-
terminal region that comprises the PH domain (Fig. 5a). If the membrane
is composed of PC lipids, then the penetrating N-terminus remains
trapped and the catalytic domaindoes not achieveproximity to themem-
brane substrate. Because the smaller and more hydrophobic PE head
groups do not anchor the N-terminus as strongly, the PH domain can
adopt different membrane orientations. The change in membrane orien-
tation of the PH domain to such a pre-active orientation triggers a change
in the relative orientation of the catalytic domain that brings the active
site close to the membrane surface (Fig. 5b). This change of the interdo-
main orientation is seen experimentally as a decrease in the distance be-
tween the PH and catalytic domains upon binding to PEmembranes and
Gβγ subunits, and is evidenced by changes in the accessibility of Cys and
Trp residues ([41] and [65]). In this later conformation (Fig. 5b), the
PLCβ2 can interact productively with G proteins and this can further
modulate the PH-catalytic domain interactions to enhance activity.
We note that with enzyme positioned with the PH domain in the
‘pre-active’ orientation (Fig. 5b), the complex is poised to bind to G pro-
teins and move into the fully activated form, which is expected to be
stable only when the G protein is productively bound. This view of the
membrane binding sequence of steps that enables activation agrees
with the experimental ﬁndings suggesting that activation occurs upon
association of the membrane-bound species, as discussed above. As
the result of one of several activationmechanisms, the nature of this ac-
tive form is still unclear but it is likely to be distinct from Rac1-PLCβ be-
cause the latter complex can be further activated by Gβγ subunits; it is
also distinct from the very similar structure of the Gαq-PLCβ2 complex
since solution studies argue against activation of the truncated enzyme
[63,64]. We propose that the binding of Gβγ and Gαq subunits induce
furthermovement between the domains as indicated by FRETmeasure-
ments ([41] and [65]). Based on the enzymatic reaction (Fig. 3), it is
tempting to speculate that the insertion region on the PH domain regu-
lates substrate entry into the active site, whereas Gβγ catalyzes product
removal from the active site. This model is presently being tested using
single molecule ﬂuorescence methods.
9. Conclusions and future challenges
PLCβ is an interesting example of how an increasing the number of
regulatory domains increases the number of ways the enzyme activity
can be modulated. While we focused here on activation mechanisms
that involve movement between the PH and catalytic domains, the
mechanism throughwhichGαq binds to the C2 domain and induces ac-
tivation through the C-terminus is unknown. It is clear that each regula-
tory domain introduces different modes of regulation that can be
autoinhibitory, as in the case of the insertion region, or target the pro-
tein to membrane surfaces containing substrate and other activation
proteins, as is the case for the PH domain. Our model of G protein acti-
vation presented above accounts for many experimental and structural
facets of PLCβ activation, although an understanding of how interdo-
main movement produces activation on the molecular scale is not yet
available. Nor can our model explain the large activation of PLCβ by
Gβ86-105 that is additive to Gβγ stimulation. Studies that combinemu-
tagenesis with advanced spectroscopic and computational methods
should provide further insight into the manner in which the various
modes of regulation of PLCβ enzymeswork together to produce the cel-
lular phenotypes of action of these important proteins.
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